Lexology January 10, 2024
Morrison & Foerster LLP

The year 2023 was a busy one for regulatory, compliance, and enforcement developments in the healthcare and life sciences industries, and 2024 promises to be even busier. We tapped MoFo’s Life Sciences + Healthcare Compliance and Enforcement Group for a 2024 preview, and here is what our team of former government officials from the U.S. Department of Justice (DOJ), Food and Drug Administration (FDA), and Department of Health and Human Services (HHS), former in-house compliance counsel, privacy lawyers, and veteran defense attorneys have offered up.

Stay tuned for a series of podcasts and webcasts from our team throughout 2024, where they will dive deep into each of the following predictions. To receive regular thought leadership and relevant event invitations, subscribe...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma / Biotech, Regulations
Pharma Pulse 2/24/25: Enhancing Pharma Supply Chain Transparency and Trust, Growing Obesity Crisis is Driving Up Healthcare Costs & more
Manas AI Launches to Transform Discovery of Novel Cancer Medicines
Trump administration, pharma clash: 4 notes
Nvidia Invests Further Into Healthcare And Releases The Largest Biology Foundation Model With The Arc Institute
PepGen Drug Shows Signs of Topping Rivals in Rare Muscle Disease With No Approved Meds

Share This Article